Detection of germline BRCA1 mutations in breast cancer patients by quantitative messenger RNA in situ hybridization.

No abstract is available for this paper.

• Publication year

  1996

• Venue

  Cancer Research

• Publication date

  1996-07-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 8674039
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer

  2004cited by this paper
• Founding BRCA1 mutations in hereditary breast and ovarian cancer in southern Sweden.

  1996cited by this paper
• A high incidence of BRCA1 mutations in 20 breast-ovarian cancer families.

  1996cited by this paper
• The carrier frequency of the BRCA1 185delAG mutation is approximately 1 percent in Ashkenazi Jewish individuals

  1995cited by this paper
• mRNA stability in mammalian cells.

  1995cited by this paper
• A collaborative survey of 80 mutations in the BRCA1 breast and ovarian cancer susceptibility gene. Implications for presymptomatic testing and screening.

  1995cited by this paper
• Age at diagnosis as an indicator of eligibility for BRCA1 DNA testing in familial breast cancer

  1995cited by this paper
• The developmental pattern of Brca1 expression implies a role in differentiation of the breast and other tissues

  1995cited by this paper
• Decreased expression of BRCA1 accelerates growth and is often present during sporadic breast cancer progression

  1995cited by this paper
• Aberrant Subcellular Localization of BRCA1 in Breast Cancer

  1995cited by this paper
• Inherited breast and ovarian cancer.

  1995influential reference
• Identification and characterization of genes that are required for the accelerated degradation of mRNAs containing a premature translational termination codon.

  1995cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994influential reference
• BRCA1 mutations in primary breast and ovarian carcinomas.

  1994cited by this paper
• The APC gene product in normal and tumor cells.

  1993cited by this paper
• Allele losses in the region 17q12–21 in familial breast and ovarian cancer involve the wild–type chromosome

  1992cited by this paper
• Mutations in the RB1 gene and their effects on transcription

  1989cited by this paper

• ABUNDANCE OF BRCA 1 TRANSCRIPTS IN HUMAN CANCER AND LYMPHOBLASTOID CELL LINES CARRYING BRCA 1 GERMLINE ALTERATIONS

  2018cites this paper
• Reduced BRCA1 transcript levels in freshly isolated blood leukocytes from BRCA1 mutation carriers is mutation specific

  2016cites this paper
• A Pilot Study on Screening of BRCA1 Mutations (185delAG, 1294del40) in Nepalese Breast Cancer Patients.

  2016cites this paper
• The Effect of Physical Activity and Body Size on BRCA1 mRNA Expression

  2015cites this paper
• The Effect of Physical Activity and Body Size on BRCA 1 mRNA Expression

  2015cites this paper
• The effect of the histone deacetylase inhibitor M344 on BRCA1 expression in breast and ovarian cancer cells

  2011cites this paper
• Enhancing the efficacy of platinum-based chemotherapeutics by targeting BRCA1

  2010cites this paper
• Loss of nuclear BRCA1 protein staining in normal tissue cells derived from BRCA1 and BRCA2 mutation carriers.

  2007cites this paper
• Chapter 3 – The Genetics of Breast and Gynecologic Cancers

  2007cites this paper
• Systematischer Vergleich der Testverfahren

  2005cites this paper
• The quest for a tumor suppressor gene phenotype.

  2003cites this paper
• Opposing effects of dietary n-3 and n-6 fatty acids on mammary carcinogenesis: The Singapore Chinese Health Study

  2003influential citation
• Promoter hypermethylation and post-transcriptional mechanisms for reduced BRCA1 immunoreactivity in sporadic human breast cancers.

  2002cites this paper
• Loss of nuclear BRCA1 localization in breast carcinoma is age dependent

  2002cites this paper
• HUMAN PROSTATE-SPECIFIC ANTIGEN AND GLANDULAR KALLIKREIN 2

  2002cites this paper
• Reduced Brca1 protein expression in 2‐amino‐1‐methyl‐6‐phenylimidazo[4,5‐b]pyridine–induced rat mammary carcinomas

  2002cites this paper
• 16 Role of prostate-specific glandular kallikrein 2 in prostate carcinoma

  2002cites this paper
• 14 - Role of Immunohistochemical Detection of BRCA1 in Breast Cancer

  2002cites this paper
• PDFlib PLOP: PDF Linearization, Optimization, Protection Page inserted by evaluation version

  2001cites this paper
• Comparison of human prostate specific glandular kallikrein 2 and prostate specific antigen gene expression in prostate with gene amplification and overexpression of prostate specific glandular kallikrein 2 in tumor tissue

  2001cites this paper
• The TMPRSS2 gene encoding transmembrane serine protease is overexpressed in a majority of prostate cancer patients: Detection of mutated TMPRSS2 form in a case of aggressive disease

  2001cites this paper
• Comparative analysis of two-dimensional protein patterns in malignant and normal human breast tissue.

  2001cites this paper
• TH ETMPRSS 2GEN EENCODIN GTRANSMEMBRAN ESERIN EPROTEAS EIS OVEREXPRESSE DI NA MAJORIT YO FPROSTAT ECANCE RPATIENTS: DETECTIO NO FMUTATE DTMPRSS 2FOR MI NA CASE O FAGGRESSIV EDISEASE

  2001cites this paper
• The usefulness of antibodies to the BRCA1 protein in detecting the mutated BRCA1 gene. An immunohistochemical study

  2001cites this paper
• Molecular analysis of sporadic breast cancer in younger women

  2001cites this paper
• Expression of Brca1 and splice variant Brca1Δ11 RNA levels in mouse mammary gland during normal development and tumorigenesis

  2000cites this paper
• Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma

  2000cites this paper
• Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.

  2000cites this paper
• Reduction of BRCA1 protein expression in Japanese sporadic breast carcinomas and its frequent loss in BRCA1-associated cases.

  1999cites this paper
• Amplification and overexpression of p40 subunit of eukaryotic translation initiation factor 3 in breast and prostate cancer.

  1999cites this paper
• Predisposing genes in hereditary breast and ovarian cancer

  1999cites this paper
• Quantification of BRCA1 protein in sporadic breast carcinoma with or without loss of heterozygosity of the BRCA1 gene

  1999cites this paper
• Reduction of BRCA 1 Protein Expression in Japanese Sporadic Breast Carcinomas and Its Frequent Loss in BRCA 1-associated Cases

  1999cites this paper
• BRCA1 and BRCA2 in breast cancer

  1999cites this paper
• Biological Functions of the BRCA1 and BRCA2 Proteins

  1999cites this paper
• Biological basis of genetic predisposition to breast cancer

  1999cites this paper
• Breast cancer susceptibility genes. BRCA1 and BRCA2.

  1998cites this paper
• Expression of BRCA1 and BRCA2 in Normal and Neoplastic Cells

  1998cites this paper
• Survival of BRCA1 breast and ovarian cancer patients: a population-based study from southern Sweden.

  1998cites this paper
• BRCA1 Gene Expression in Reproductive and Endocrine Tissues in Adult Cynomolgus Monkey

  1998cites this paper
• Decreased BRCA1 expression levels may arrest the cell cycle through activation of p53 checkpoint in human sporadic breast tumors.

  1998cites this paper
• Abundance of BRCA1 transcripts in human cancer and lymphoblastoid cell lines carrying BRCA1 germ‐line alterations

  1997cites this paper
• Localization of BRCA1 Gene Expression in Adult Cynomolgus Monkey Tissues

  1997cites this paper
• Clinical chemistry.

  1997cites this paper
• Moderate frequency of BRCA1 and BRCA2 germ-line mutations in Scandinavian familial breast cancer.

  1997cites this paper
• Tumor suppressor genes and human cancer.

  1997cites this paper